Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125316291 | 12531629 | 1 | I | 201512 | 20160308 | 20160706 | 20160706 | EXP | PR-ABBVIE-16P-131-1580985-00 | ABBVIE | 64.60 | YR | F | Y | 88.98000 | KG | 20160706 | CN | COUNTRY NOT SPECIFIED | PR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125316291 | 12531629 | 1 | PS | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | UNKNOWN | 21402 | 112 | MG | TABLET | QD | ||||||
| 125316291 | 12531629 | 2 | C | DILTIAZEM HYDROCHLORIDE. | DILTIAZEM HYDROCHLORIDE | 1 | Oral | 0 | 240 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125316291 | 12531629 | 1 | Hypothyroidism |
| 125316291 | 12531629 | 2 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125316291 | 12531629 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125316291 | 12531629 | Asthma | |
| 125316291 | 12531629 | Cough | |
| 125316291 | 12531629 | Dyspnoea | |
| 125316291 | 12531629 | Headache |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125316291 | 12531629 | 1 | 2006 | 0 | ||
| 125316291 | 12531629 | 2 | 2015 | 0 |